Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine

Area of Science:

• Neuroscience
• Psychopharmacology
• Biochemistry

Background:

• The role of endogenous N,N-dimethyltryptamine (DMT) in human physiology has been debated for decades.
• Early research linking DMT to psychosis and schizophrenia yielded inconclusive results.
• Recent discovery of human trace amine receptors (TA receptors) prompts re-evaluation of psychoactive compounds' biological roles.

Purpose of the Study:

• To investigate the potential role of endogenous DMT in human mental states.
• To explore the interaction of DMT and related tryptamines with newly discovered trace amine receptors.
• To propose a novel hypothesis regarding DMT's effects on psychosis and the calming effects of amphetamines.

Main Methods:

• Review of existing literature on endogenous DMT, psychosis, and trace amine receptors.
• Analysis of proposed interactions between DMT, TA receptors, and serotonin 5-HT(2A) receptors.
• Hypothetical modeling of endogenous DMT's effects on mental state and amphetamine's actions.

Main Results:

• Psychoactive tryptamines, including DMT, elicit a significant response at TA receptors.
• Exogenous DMT, particularly at low doses, may exert effects via TA receptor activity, not solely through 5-HT(2A) receptors.
• Endogenous DMT interaction with TA receptors could promote a relaxed state, potentially mitigating psychosis symptoms.

Conclusions:

• Endogenous DMT may interact with TA receptors to induce a calming mental state, offering an alternative explanation for its presence in humans.
• This hypothesis reconciles inconsistencies in early DMT research and suggests a potential mechanism for the anxiolytic effects of amphetamines at low doses.
• Further research into TA receptor pharmacology is warranted to elucidate the precise roles of endogenous tryptamines and related compounds.